Rahmani, M., Aust, M. M., Hawkins, E., Parker, R. E., Ross, M., Kmieciak, M., Reshko, L. B., Rizzo, K. A., Dumur, C. I., Ferreira-Gonzalez, A. and Grant, S. (2015) “Co-administration of the mTORC1/TORC2 inhibitor INK128 and the Bcl-2/Bcl-xL antagonist ABT-737 kills human myeloid leukemia cells through Mcl-1 down-regulation and AKT inactivation”, Haematologica. Pavia, Italy, 100(12), pp. 1553-1563. doi: 10.3324/haematol.2015.130351.